Audited Financial Results for the Half year and year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hannah Joseph Hospital reported strong full-year results for FY2026. Revenue from operations grew 18.7% to ₹920.52 lakhs (FY2025: ₹775.31 lakh). Profit after tax rose 36.6% to ₹75.10 lakhs (FY2025: ₹54.99 lakh), outpacing revenue growth. EBITDA margin expanded significantly to ~24.7% from ~17.6% in the prior year, driven by better cost control. The company raised ₹4,200 lakh via IPO in January 2026 and as of March 31, 2026, has deployed only ₹753.29 lakh (18% utilization) with the balance in fixed deposits. Borrowings reduced from ₹335.78 lakh to ₹250.89 lakh, improving the debt-to-equity ratio. The Board recommended a final dividend of ₹2 per share (20% on face value). Statutory auditors issued an unmodified opinion.
The company delivered robust earnings growth with margin expansion, indicating operational efficiency improvements. The heavy IPO cash pile (₹3,447 lakh unutilized) and reduced debt are positives, though investors may watch for deployment pace. PAT growth of 36.6% exceeds the 25% threshold signal.